Thalidomide: Tragic past and promising futureRAJKUMAR, S. Vincent.Mayo Clinic proceedings. 2004, Vol 79, Num 7, pp 899-903, issn 0025-6196, 5 p.Article

Thalidomide: 40 years onDIGGLE, G. E.International journal of clinical practice (Esher). 2001, Vol 55, Num 9, pp 627-631, issn 1368-5031Article

Thalidomide : le retour = ThalidomideKNOLL, Maël.Biofutur (Puteaux). 2003, Vol 238, pp 42-43, issn 0294-3506, 2 p.Article

Thalidomide and sensory neurotoxicity : a neurophysiological studyZARA, G; ERMANI, M; RONDINONE, R et al.Journal of neurology, neurosurgery and psychiatry. 2008, Vol 79, Num 11, pp 1258-1261, issn 0022-3050, 4 p.Article

Thalidomide radiosensitizes tumors through early changes in the tumor microenvironmentANSIAUX, Réginald; BAUDELET, Christine; JORDAN, Bénédicte F et al.Clinical cancer research. 2005, Vol 11, Num 2, pp 743-750, issn 1078-0432, 8 p., 1Article

The schizophrenic career of a monster drugSILVERMAN, William A.Pediatrics (Evanston). 2002, Vol 110, Num 2, pp 404-406, issn 0031-4005, 3 p., 1Article

Thalidomide sensory neurotoxicity: A clinical and neurophysiologic studyCAVALETTI, G; BERONIO, A; PLASMATI, R et al.Neurology. 2004, Vol 62, Num 12, pp 2291-2293, issn 0028-3878, 3 p.Article

Thalomid® (Thalidomide) capsules: A review of the first 18 months of spontaneous postmarketing adverse event surveillance, including off-label prescribingCLARK, Todd E; EDOM, Norma; LARSON, Janice et al.Drug safety. 2001, Vol 24, Num 2, pp 87-117, issn 0114-5916Article

Thalidomide as a novel therapeutic agent: new uses for an old productK.TEO, Steve; STIRLING, David I; ZELDIS, Jerome B et al.Drug discovery today. 2005, Vol 10, Num 2, pp 107-114, issn 1359-6446, 8 p.Article

ThalidomideFRANKS, Michael E; MACPHERSON, Gordon R; FIGG, William D et al.Lancet (British edition). 2004, Vol 363, Num 9423, pp 1802-1811, issn 0140-6736, 10 p.Article

Treatment of plasma cell dyscrasias with thalidomide and its derivativesDIMOPOULOS, Meletios A; ANAGNOSTOPOULOS, Athanasios; WEBER, Donna et al.Journal of clinical oncology. 2003, Vol 21, Num 23, pp 4444-4454, issn 0732-183X, 11 p.Article

Prise en charge d'un patient sous thalidomide = Managenment of a patient receiving thalidomideBROCVIELLE, Hélène; MURET, Patrice; PLENAT, Emmanuel et al.La Presse médicale (1983). 2003, Vol 32, Num 40, pp 1894-1898, issn 0755-4982, 5 p.Article

Peculiarities and possible mode of actions of thalidomideNEUBERT, R; NEUBERT, D.Handbook of experimental pharmacology. 1997, Vol 124, pp 41-119, issn 0171-2004, 2Article

Treatment of prurigo nodularis with thalidomide: a case report and review of the literatureALFADLEY, Abdullah; AL-HAWSAWI, Khalid; THESTRUP-PEDERSEN, Kristian et al.International journal of dermatology. 2003, Vol 42, Num 5, pp 372-375, issn 0011-9059, 4 p.Article

Lintérêt du thalidomide est confirmé dans le myélome du sujet âgéCHAGNON, André.Concours médical (Paris). 2006, Vol 128, Num 17-18, pp 737-738, issn 0010-5309, 2 p.Article

Therapeutic renaissance of thalidomide in the treatment of haematological malignanciesRIBATTI, D; VACCA, A.Leukemia. 2005, Vol 19, Num 9, pp 1525-1531, issn 0887-6924, 7 p.Article

Thalidomide in solid tumours: the resurrection of an old drugSLEIJFER, Stefan; KRUIT, Wim H. J; STOTER, Gerrit et al.European journal of cancer (1990). 2004, Vol 40, Num 16, pp 2377-2382, issn 0959-8049, 6 p.Article

Clinical pharmacokinetics of thalidomideTEO, Steve K; COLBURN, Wayne A; TRACEWELL, William G et al.Clinical pharmacokinetics. 2004, Vol 43, Num 5, pp 311-327, issn 0312-5963, 17 p.Article

Thalidomide abolishes transfusion-dependence in selected patients with myelodysplastic syndromesMUSTO, Pellegrino; FALCONE, Antonietta; SANPAOLO, Grazia et al.Haematologica (Roma). 2002, Vol 87, Num 8, pp 884-886, issn 0390-6078Article

Thalidomide dose proportionality assessment following single doses to healthy subjectsTEO, Steve K; SCHEFFLER, Michael R; KOOK, Karin A et al.Journal of clinical pharmacology. 2001, Vol 41, Num 6, pp 662-667, issn 0091-2700Article

Thalidomide is distributed into human semen after oral dosingTEO, Steve K; HARDEN, Jill L; BURKE, Alison B et al.Drug metabolism and disposition. 2001, Vol 29, Num 10, pp 1355-1357, issn 0090-9556Article

Thalidomide produces transfusion independence in long-standing refractory anemias of patients with myelodysplastic syndromesRAZA, Azra; MEYER, Peter; DAR, Saleem et al.Blood. 2001, Vol 98, Num 4, pp 958-965, issn 0006-4971Article

Hypothesis : Thalidomide embryopathy : Proposed mechanism of actionSTEPHENS, T. D; FILLMORE, B. J.Teratology (Philadelphia, PA). 2000, Vol 61, Num 3, pp 189-195, issn 0040-3709Article

Recalcitrant pyoderma gangrenosum : Treatment with thalidomideHECKER, M. S; LEBWOHL, M. G.Journal of the American Academy of Dermatology. 1998, Vol 38, Num 3, pp 490-491, issn 0190-9622Article

Thalidomide : was the tragedy preventable?DALLY, A.Lancet (British edition). 1998, Vol 351, Num 9110, pp 1197-1199, issn 0140-6736Article